PCK2 and prostate cancer: First, we found that selected TIC-enriched prostate cancer cell clones use more glucose and secrete more lactate than their TIC-low counterparts.Second,we determined that PCK2 is critical for the metabolic switch that generates and maintains TICs in prostate cancer.